| Peer-Reviewed

Inflammatory Breast Cancer: Still a Diagnostic Dilemma

Received: 4 March 2014     Accepted: 26 May 2014     Published: 10 June 2014
Views:       Downloads:
Abstract

Background: Inflammatory breast cancer (IBC) is a rapidly progressive disease associated with high mortality in developing countries. The patients are managed for mastitis’s first and IBC becomes a diagnosis of exclusion after failed response to appropriate antibiotic therapy. This study was aimed at evaluating the outcome of management of IBC in North central Nigeria. Patients and method: This was a prospective analysis of consecutive patients presenting with breast cancer at the Abubakar Tafawa Balewa University teaching hospital Bauchi (ATBUTH) from January 2011 to December 2012. Results: A total of 52 breast cancers were managed, mean age was 31+/- 2years with an age range of 29 -33 years. There were 51 females and 1male (f: m = 51:1). IBC accounted for 9(17.3 %) of the breast cancers. Conclusion: IBC is frequently misdiagnosed as mastitis for various reasons and a high index of suspicion is required to clinch the diagnosis.

Published in Journal of Surgery (Volume 2, Issue 3)
DOI 10.11648/j.js.20140203.12
Page(s) 42-45
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

Inflammatory, Breast, Cancer, Mastitis, Misdiagnosis

References
[1] Schlichting, J. A.;Soliman, A. S. ;Schairer, C.;Schottenfeld, D.;Merajver, S. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Department of Epidemiology, University of Michigan School of Public Health, 109 Observatory St., Ann Arbor, MI 48109-2029, USA. jschlic@umich.edu
[2] Waller KP. Mammary gland immunology around parturition. Influence of stress, nutrition and genetics. Adv Exp Med Biol. 2000;480:231-45.
[3] Tabbane F, el May A, Hachiche M, Bahi J, Jaziri M, Cammoun M, et al. Breast cancer in women under 30 years of age. Breast Cancer Res Treat. 1985;6(2):137-44.
[4] Dahl beck SW, Donnelly JF, Theriault RL. Differentiating inflammatory breast cancer from acute mastitis. The Family physician 1995 Sep 1; 52(3):929-34. University of Minnesota Hospital and Clinic, Minneapolis, USA.
[5] Alunni JP. Imaging inflammatory breast cancer. Diagn Interv Imaging. 2012 Feb;93(2):95-103.
[6] Uematsu T. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer,2012 Oct;19(4):289-94. doi: 10.1007/s12282-012-0346-1. Epub 2012 Feb 21.Breast Imaging and Breast Intervention Section, Shizuoka Cancer Center Hospital, Naga-izumi, Shizuoka, 411-8777, Japan. t.uematsu@scchr.j
[7] Anne N, Pallapothu R. Lymphoma of the breast: a mimic of inflammatory breast cancer. World J Surg Oncol. 2011;9:125.
[8] Alvarez RH, Gong Y, Ueno NT, Alizadeh PA, Hortobagyi GN, Valero V. Metastasis in the breast mimicking inflammatory breast cancer. J Clin Oncol. 2012 Aug 1;30(22):e202-6.
[9] Li BD, Sicard MA, Ampil F, Abreo F, Lilien D, Chu QD, Burton GV. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3. Department of Surgery, Radiology, Pathology and Medicine, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center, Shreveport, La 71130, USA. bli@lsuhsc.edu
[10] Boussen H, Bouzaiene H, Ben Hassouna J, Dhiab T, Khomsi F, Benna F, et al. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Cancer. 2010 Jun 1;116(11 Suppl):2730-5.
[11] Meyer KK. Diagnostic error in breast disease. Am Surg. 1975 Dec;41(12):774-85.
[12] Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Cristofanilli M. Inflammatory breast cancer: the disease, the biology, the treatment. C A Cancer J Clin. 2010 Nov-Dec;60(6):351-75. doi: 10.3322/caac.20082. Epub 2010 Oct Department of Experimental Therapeutics, the University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.CA Cancer J Clin. 2011 Mar-Apr; 61(2):134. Ueno, Naoto [corrected to Ueno, Naoto T].
[13] Abrous-Anane S, Savignoni A, Daveau C, Pierga JY, Gautier C, Reyal F, et al. [Management of inflammatory breast cancer after neo-adjuvant chemotherapy]. Cancer Radiother. 2011 Dec;15(8):654-62.
[14] Abdulrahman GO, Jr., Rahman GA. Epidemiology of breast cancer in europe and Africa. J Cancer Epidemiol. 2012;2012:915610.
[15] Shah NM, Soliman AS, Benerjee M, Merajver SD, Ismail K, Seifeldin I, et al. Knowledge gained after a brief CME module on breast cancer diagnosis. J Cancer Educ. 2006 Fall; 21(3):169-74.
[16] Dauda AM, Misauno MA, Ojo EO. Histopathological types of breast cancer in Gombe, North Eastern Nigeria: a seven-year review. Afr J Reprod Health. 2011 Mar;15(1):109-11.
[17] Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, et al. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat. 2008 Nov;112(1):141-7.
[18] Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, et al. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat. 2008 Nov;112(1):141-7.
[19] Labidi SI, Mrad K, Mezlini A, Ouarda MA, Combes JD, Ben Abdallah M, et al. In-flammatory breast cancer in Tunisia in the era of multimodality therapy. Ann Oncol. 2008 Mar;19(3):473-80.
Cite This Article
  • APA Style

    W. M. Isichei, M. A. Misauno. (2014). Inflammatory Breast Cancer: Still a Diagnostic Dilemma. Journal of Surgery, 2(3), 42-45. https://doi.org/10.11648/j.js.20140203.12

    Copy | Download

    ACS Style

    W. M. Isichei; M. A. Misauno. Inflammatory Breast Cancer: Still a Diagnostic Dilemma. J. Surg. 2014, 2(3), 42-45. doi: 10.11648/j.js.20140203.12

    Copy | Download

    AMA Style

    W. M. Isichei, M. A. Misauno. Inflammatory Breast Cancer: Still a Diagnostic Dilemma. J Surg. 2014;2(3):42-45. doi: 10.11648/j.js.20140203.12

    Copy | Download

  • @article{10.11648/j.js.20140203.12,
      author = {W. M. Isichei and M. A. Misauno},
      title = {Inflammatory Breast Cancer: Still a Diagnostic Dilemma},
      journal = {Journal of Surgery},
      volume = {2},
      number = {3},
      pages = {42-45},
      doi = {10.11648/j.js.20140203.12},
      url = {https://doi.org/10.11648/j.js.20140203.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20140203.12},
      abstract = {Background: Inflammatory breast cancer (IBC) is a rapidly progressive disease associated with high mortality in developing countries. The patients are managed for mastitis’s first and IBC becomes a diagnosis of exclusion after failed response to appropriate antibiotic therapy. This study was aimed at evaluating the outcome of management of IBC in North central Nigeria. Patients and method: This was a prospective analysis of consecutive patients presenting with breast cancer at the Abubakar Tafawa Balewa University teaching hospital Bauchi (ATBUTH) from January 2011 to December 2012. Results: A total of 52 breast cancers were managed, mean age was 31+/- 2years with an age range of 29 -33 years. There were 51 females and 1male (f: m = 51:1).  IBC accounted for 9(17.3 %) of the breast cancers. Conclusion: IBC is frequently misdiagnosed as mastitis for various reasons and a high index of suspicion is required to clinch the diagnosis.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Inflammatory Breast Cancer: Still a Diagnostic Dilemma
    AU  - W. M. Isichei
    AU  - M. A. Misauno
    Y1  - 2014/06/10
    PY  - 2014
    N1  - https://doi.org/10.11648/j.js.20140203.12
    DO  - 10.11648/j.js.20140203.12
    T2  - Journal of Surgery
    JF  - Journal of Surgery
    JO  - Journal of Surgery
    SP  - 42
    EP  - 45
    PB  - Science Publishing Group
    SN  - 2330-0930
    UR  - https://doi.org/10.11648/j.js.20140203.12
    AB  - Background: Inflammatory breast cancer (IBC) is a rapidly progressive disease associated with high mortality in developing countries. The patients are managed for mastitis’s first and IBC becomes a diagnosis of exclusion after failed response to appropriate antibiotic therapy. This study was aimed at evaluating the outcome of management of IBC in North central Nigeria. Patients and method: This was a prospective analysis of consecutive patients presenting with breast cancer at the Abubakar Tafawa Balewa University teaching hospital Bauchi (ATBUTH) from January 2011 to December 2012. Results: A total of 52 breast cancers were managed, mean age was 31+/- 2years with an age range of 29 -33 years. There were 51 females and 1male (f: m = 51:1).  IBC accounted for 9(17.3 %) of the breast cancers. Conclusion: IBC is frequently misdiagnosed as mastitis for various reasons and a high index of suspicion is required to clinch the diagnosis.
    VL  - 2
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Surgery, Jos University Teaching Hospital Jos, Plateau state Nigeria

  • Department of Surgery, Jos University Teaching Hospital Jos, Plateau state Nigeria

  • Sections